Sitaram Velaga, Ph.D.

CEO
Kenox Pharmaceutical Inc.

Poster(s):

• (T1030-09-52) Weekly Apixaban Transdermal Delivery System
  Tuesday, October 22, 2024

  10:30 AM – 11:30 AM MT

• (T1130-09-52) A Modelling and Simulation Assessment of Steady State Apixaban Delivered from a Weekly Transdermal Patch
  Tuesday, October 22, 2024

  11:30 AM – 12:30 PM MT

• (M1430-09-52) Development of Dry Powder Formulation of PAV-104 for Pulmonary Drug Delivery
  Monday, October 21, 2024

  2:30 PM – 3:30 PM MT